Cargando…
The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function
AIMS/HYPOTHESIS: Studies in permanent neonatal diabetes suggest that sulphonylureas lower blood glucose without causing hypoglycemia, in part by augmenting the incretin effect. This mechanism has not previously been attributed to sulphonylureas in patients with type 2 diabetes (T2DM). We therefore a...
Autores principales: | Cordiner, Ruth L M, Mari, Andrea, Tura, Andrea, Pearson, Ewan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692237/ https://www.ncbi.nlm.nih.gov/pubmed/33693776 http://dx.doi.org/10.1210/clinem/dgab151 |
Ejemplares similares
-
Assessing the Effect of Incretin Hormones and Other Insulin Secretagogues on Pancreatic Beta-Cell Function: Review on Mathematical Modelling Approaches
por: Pacini, Giovanni, et al.
Publicado: (2022) -
Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
por: Pacini, G., et al.
Publicado: (2012) -
Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype
por: Dujic, Tanja, et al.
Publicado: (2021) -
Fabrication and Characterization of Gliclazide Nanocrystals
por: Ravouru, Nagaraju, et al.
Publicado: (2018) -
β-Cell Function, Incretin Effect, and Incretin Hormones in Obese Youth Along the Span of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes
por: Michaliszyn, Sara F., et al.
Publicado: (2014)